Clinical Trials Logo
  1. Home
  2. Smoking, Cigarette
  3. NCT04003805

Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users

Smoking, Cigarette Clinical Trial

Official title:
Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users

Clinical Trial Summary

This study is focused on characterizing the toxic and carcinogenic potential of the Standardized Research E-cigarette (SREC) developed by the National Institute on Drug Abuse. In the environment of continuously changing e-cigarette market, SREC was developed as a model e-cigarette that will remain available for an extended period of time and can be used as a bridging element in various studies aimed at evaluating the value and limitations of e-cigarettes as tobacco risk reduction tools. Our overall goal is to generate initial reference data on chemical exposures and associated effects in smokers switching to SREC.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04003805
Study type Interventional
Source Masonic Cancer Center, University of Minnesota
Contact Hanna Vanderloo, RN, MSN
Phone 612.624.4983
Email hannav@umn.edu
Status Recruiting
Phase Phase 1
Start date May 11, 2022
Completion date January 20, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT03397511 - Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City N/A
Terminated NCT03576768 - QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt N/A
Recruiting NCT03802019 - Cigarette Packaging of Low Nicotine Cigarettes N/A
Completed NCT03194256 - Evaluating New Nicotine Standards for Cigarettes - Project 3 N/A
Completed NCT04808609 - Smoking Cessation Pilot for People Living With HIV (PLWH) N/A
Completed NCT03553992 - An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers N/A
Recruiting NCT03721822 - Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation Phase 1
Completed NCT05162820 - Impact of Solarplast® on Immunity in Active Smokers and Non-smokers N/A
Recruiting NCT03630614 - Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation. Phase 3
Completed NCT03502200 - Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures N/A
Completed NCT05473585 - Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2 N/A
Completed NCT04115176 - GCF IL-17 Levels and Oxidative Status of Smoking and Non-smoking Individuals With Periodontitis
Completed NCT04161144 - Enhancing Self Regulation Among Smokers Phase 2
Completed NCT03364751 - Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome N/A
Recruiting NCT05973981 - The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment N/A
Recruiting NCT06190860 - Platelet Rich Fibrin Treatment for the Alveolar Ridge Preservation in Smokers N/A
Recruiting NCT03814434 - Surgical Treatment of Periimplantitis in Patients With Risk Factors N/A
Completed NCT03569748 - Heated Tobacco Products vs Electronic Cigarettes N/A
Completed NCT03500965 - Pictorial Warning Labels and Memory for Relative and Absolute Cigarette Health-risk Information Over Time in Teens N/A
Completed NCT03642041 - Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients